Neuraxis, Inc. (NRXS) vs VAXART, INC. (VXRT)
Neuraxis, Inc. and VAXART, INC. are both Biotechnology companies. Neuraxis, Inc. and VAXART, INC. are of similar size ($97.3M and $92.4M). Neuraxis, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. grew revenue faster over the last twelve months: 201.1% against 65.2%. VAXART, INC. has the higher net margin (15.9% vs −159.0%) and the higher return on invested capital (134.6% vs 0.00%). Across the 17 metrics below, VAXART, INC. leads on 16 and Neuraxis, Inc. on 1.
Valuation
Profitability
| Metric | NRXS | VXRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 85.56% | 100.00% | 65.16% |
| Operating margin | (144.51%) | 16.30% | 0.00% |
| Net margin | (159.01%) | 15.88% | 0.00% |
| Free cash flow margin | (106.10%) | 13.74% | 0.00% |
| Return on equity | (153.96%) | 66.97% | (57.72%) |
| Return on assets | (98.96%) | 23.44% | (49.22%) |
| Return on invested capital | 0.00% | 134.59% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack